Product Information

BRIMONIDINE-TIMOLOL 0.2%-0.5% is a generic product labeled by Pacific Pharma, Inc., priced at $1.8390 per ML under NDC 82182045515. Its NADAC has been published 197 times since Nov 16, 2022.

FDA first approved this application on Oct 30, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE-TIMOLOL 0.2%-0.5%

BRIMONIDINE TARTRATE, TIMOLOL MALEATE
$1.8390per ML

Strength

2; 5 mg/mL; mg/mL

NDC

82182045515

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

TOPICAL

Effective Date

8/19/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021398

FDA Approved

10/30/2007

TE Code

AB

On Market Since

10/21/2022

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Antagonists
alpha-Adrenergic Agonist
beta-Adrenergic Blocker

Price Statistics

The NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has been published 197 times since Nov 16, 2022, and over the history we have for it it has declined 93.8%. The table below summarizes its recorded NADAC range and movement.

Current price$1.8390 per ML
All-time high$30.7775 (Dec 14, 2022)
All-time low$1.8390 (Aug 19, 2026)
52-week high$6.8975
52-week low$1.8390
Median price$8.8093
Average price$10.3717
Largest weekly change+75.9% (Aug 21, 2024)
Weeks tracked197
Tracking sinceNov 16, 2022

Price History

1W

-4.8%

1M

-4.8%

3M

-22.8%

6M

-27.3%

1Y

-72.3%

3Y

-88.4%

5Y

N/A

All

-93.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BRIMONIDINE-TIMOLOL 0.2%-0.5%?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE-TIMOLOL 0.2%-0.5%, manufactured by Pacific Pharma, Inc., is $1.8390 per ML (NDC 82182045515), effective Aug 19, 2026.

How has the price of BRIMONIDINE-TIMOLOL 0.2%-0.5% changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has declined 93.8%. It has been tracked across 197 weekly CMS publications since Nov 16, 2022.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Since Nov 16, 2022, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has ranged from a low of $1.8390 (Aug 19, 2026) to a high of $30.7775 (Dec 14, 2022), with a median of $8.8093 per ML.

Are there cheaper alternatives to BRIMONIDINE-TIMOLOL 0.2%-0.5%?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BRIMONIDINE-TIMOLOL 0.2%-0.5% in a comparable dosage form, but none are currently priced below it.

Who manufactures BRIMONIDINE-TIMOLOL 0.2%-0.5%?

BRIMONIDINE-TIMOLOL 0.2%-0.5% (NDC 82182045515) is labeled by Pacific Pharma, Inc., and CMS classifies it as a generic product.